Cargando…
Clinical-grade whole-genome sequencing and 3′ transcriptome analysis of colorectal cancer patients
BACKGROUND: Clinical-grade whole-genome sequencing (cWGS) has the potential to become the standard of care within the clinic because of its breadth of coverage and lack of bias towards certain regions of the genome. Colorectal cancer presents a difficult treatment paradigm, with over 40% of patients...
Autores principales: | Stodolna, Agata, He, Miao, Vasipalli, Mahesh, Kingsbury, Zoya, Becq, Jennifer, Stockton, Joanne D., Dilworth, Mark P., James, Jonathan, Sillo, Toju, Blakeway, Daniel, Ward, Stephen T., Ismail, Tariq, Ross, Mark T., Beggs, Andrew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908713/ https://www.ncbi.nlm.nih.gov/pubmed/33632293 http://dx.doi.org/10.1186/s13073-021-00852-8 |
Ejemplares similares
-
Patient Derived Organoids Confirm That PI3K/AKT Signalling Is an Escape Pathway for Radioresistance and a Target for Therapy in Rectal Cancer
por: Wanigasooriya, Kasun, et al.
Publicado: (2022) -
MicroRNA changes in maternal serum from pregnancies complicated by twin‐twin transfusion syndrome: A discovery study
por: Mackie, Fiona L., et al.
Publicado: (2019) -
Validation of epigenetic markers to identify colitis associated cancer: Results of module 1 of the ENDCAP-C study
por: Beggs, Andrew D., et al.
Publicado: (2018) -
Whole-genome sequencing provides new insights into the clonal architecture of Barrett’s esophagus and esophageal adenocarcinoma
por: Ross-Innes, Caryn S., et al.
Publicado: (2015) -
Correction to: Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
por: Pestinger, Valerie, et al.
Publicado: (2020)